<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7546461\results\search\testTrace\results.xml">
  <result pre="the international research community, from the implementation of diagnostics and" exact="contact tracing" post="procedures to the collective search for vaccines and antiviral"/>
  <result pre="international research community, from the implementation of diagnostics and contact" exact="tracing" post="procedures to the collective search for vaccines and antiviral"/>
  <result pre="as measles in humans, this preparation includes systems for (1)" exact="detection" post="by routine surveillance, (2) confirmation by designated specialist laboratories,"/>
  <result pre="delivery of each step are annotated on the left. The" exact="detection" post="of COVID-19 and the discovery of SARS-CoV-2 When unusually"/>
  <result pre="a novel pathogen, requiring discovery methods. Virus discovery methods include" exact="polymerase chain reaction" post="(PCR) assays targeting conserved genome regions specific to all"/>
  <result pre="of a taxonomic family (potentially even unknown ones), attempted virus" exact="isolation" post="in cell culture, microscopy to study the virion morphology,"/>
  <result pre="on January 10, 2020 (Fig 2), 20 days after cluster" exact="detection" post="(GISAID accessions EPI_ISL_402119 and EPI_ISL_402121), and phylogenetic analyses showed"/>
  <result pre="the SARS-CoV-1 and SARS-CoV-2 outbreaks. COVID-19, coronavirus disease 2019; PCR," exact="polymerase chain reaction;" post="PHEIC, Public Health Emergency of International Concern; SARS-CoV-1, severe"/>
  <result pre="uncovers viral transmission dynamics to support control policies, such as" exact="prevalence" post="in vulnerable demographics [12], case fatality [13], or the"/>
  <result pre="long been deployed as a firebreak to epidemic spread. Contact" exact="tracing" post="is being applied during the current pandemic; however, with"/>
  <result pre="conduct [19]. Technological solutions in the form of privacy-protecting open-source" exact="contact tracing" post="apps have emerged rapidly, such as the TraceTogether app"/>
  <result pre="[19]. Technological solutions in the form of privacy-protecting open-source contact" exact="tracing" post="apps have emerged rapidly, such as the TraceTogether app"/>
  <result pre="become status quo tools during epidemics. In addition to diagnostic" exact="testing" post="and contact tracing, genomic epidemiology can today be used"/>
  <result pre="quo tools during epidemics. In addition to diagnostic testing and" exact="contact tracing," post="genomic epidemiology can today be used to describe the"/>
  <result pre="[27]. Although PCR is considered the gold standard for laboratory" exact="diagnosis" post="of an active SARS-CoV-2 infection [28], serological assays can"/>
  <result pre="the gold standard for laboratory diagnosis of an active SARS-CoV-2" exact="infection" post="[28], serological assays can detect historical infections and play"/>
  <result pre="for in silico modelling of proteinâ€&quot;protein interactions and high-throughput computational" exact="screening" post="of chemical compounds with potential antiviral properties. Another remarkable"/>
  <result pre="vital for numerous downstream applications, including generating these in vivo" exact="infection" post="models for therapeutic testing [44], antiviral screening [45], and"/>
  <result pre="applications, including generating these in vivo infection models for therapeutic" exact="testing" post="[44], antiviral screening [45], and fundamental virus characterisation [46]."/>
  <result pre="these in vivo infection models for therapeutic testing [44], antiviral" exact="screening" post="[45], and fundamental virus characterisation [46]. Traditionally, a clinical"/>
  <result pre="bioavailability data, allowing human clinical trials to proceed rapidly after" exact="testing" post="of in vitro efficacy. However, the repurposing of approved"/>
  <result pre="trials, the FDA granted an EUA of remdesivir for COVID-19" exact="treatment" post="on May 1, 2020 [55]. This was the first"/>
  <result pre="neutralising antibodies (nAbs) to patients early in disease is another" exact="treatment" post="option. Serum from convalescent COVID-19 patients contains anti-SARS-CoV-2 antibodies,"/>
  <result pre="in May by a humanised antibody (47D11) capable of blocking" exact="infection" post="with both SARS-CoV-1 and SARS-CoV-2 in vitro [62]. Also"/>
  <result pre="For this purpose, WHO launched the Solidarity clinical trial for" exact="testing" post="COVID-19 treatments [82], which involves over 100 countries and"/>
  <result pre="for Epidemic Preparedness Innovations https://cepi.net/ COMPARE COllaborative Management Platform for" exact="detection" post="and Analyses of (Re-)emerging and foodborne outbreaks in Europe"/>
  <result pre="https://www.recover-europe.eu/ Solidarity International clinical trial to help find an effective" exact="treatment" post="for COVID-19, launched by WHO and partners https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments VIRUS-X"/>
  <result pre="Coalition for Epidemic Preparedness Innovations; COMPARE, COllaborative Management Platform for" exact="detection" post="and Analyses of (Re-)emerging and foodborne outbreaks in Europe;"/>
  <result pre="Nature. 2020;579:270â€&quot;273. 10.1038/s41586-020-2012-732015507 12BaggettTP, KeyesH, SpornN, GaetaJM. Prevalence of SARS-CoV-2" exact="infection" post="in residents of a large homeless shelter in Boston."/>
  <result pre="RT-PCR.Eur Secur.2020;25:2000045. 16YuL, WuS, HaoX, DongX, MaoL, PelechanoV, et al.Rapid" exact="detection" post="of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal"/>
  <result pre="10.1093/clinchem/hvaa10232315390 17ZhangY, OdiwuorN, XiongJ, SunL, NyaruabaRO, WeiH, et al.Rapid molecular" exact="detection" post="of SARS-CoV-2 (COVID-19) virus RNA using colorimetric LAMP.medRxiv. 2020."/>
  <result pre="2020. 18Ben-AssaN, NaddafR, GefenT, CapuchaT, HajjoH, MandelbaumN, et al.SARS-CoV-2 on-the-spot" exact="virus detection" post="directly from patients.medRxiv.2020. 19FerrettiL, WymantC, KendallM, ZhaoL, NurtayA, Abeler-DÃ¶rnerL,"/>
  <result pre="18Ben-AssaN, NaddafR, GefenT, CapuchaT, HajjoH, MandelbaumN, et al.SARS-CoV-2 on-the-spot virus" exact="detection" post="directly from patients.medRxiv.2020. 19FerrettiL, WymantC, KendallM, ZhaoL, NurtayA, Abeler-DÃ¶rnerL,"/>
  <result pre="Abeler-DÃ¶rnerL, et al.Quantifying SARS-CoV-2 transmission suggests epidemic control with digital" exact="contact tracing." post="Science. 2020;368:eabb693610.1126/science.abb693632234805 20Google Company Announcements. 2020. Available from: https://www.blog.google/inside-google/company-announcements/apple-and-google-partner-covid-19-contact-tracing-technology/."/>
  <result pre="test setup.Curr Protoc Microbiol.2020;57:e10010.1002/cpmc.10032302069 28World Health Organization. Interim guidance: Laboratory" exact="testing" post="for 2019 novel coronavirus (2019-nCoV) in suspected human cases."/>
  <result pre="from: https://www.who.int/publications-detail/laboratory-testing-for-2019-novel-coronavirus-in-suspected-human-cases-20200117. 29SpellbergB, HaddixM, LeeR, Butler-WuS, HoltomP, YeeH, et al.Community" exact="prevalence" post="of SARS-CoV-2 among patients with influenzalike illnesses presenting to"/>
  <result pre="application of a rapid IgM-IgG combined antibody test for SARS-CoV-2" exact="infection" post="diagnosis. J Med Virol. 2020:1â€&quot;7. 32BroughtonJP, DengX, YuG, FaschingCL,"/>
  <result pre="Virol. 2020:1â€&quot;7. 32BroughtonJP, DengX, YuG, FaschingCL, SinghJ, StreithorstJ, et al.Rapid" exact="detection" post="of 2019 novel coronavirus SARS-CoV-2 using a CRISPR-based DETECTR"/>
  <result pre="53TouretF, GillesM, BarralK, NougairÃ¨deA, DecrolyE, de LamballerieX, et al.In vitro" exact="screening" post="of a FDA approved chemical library reveals potential inhibitors"/>
 </snippets>
</snippetsTree>
